<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38549052</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany.</ArticleTitle><Pagination><StartPage>915</StartPage><MedlinePgn>915</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">915</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-18380-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies estimate that at least 7.5% of adults are affected by long-term symptoms such as fatigue or cognitive impairment after the acute phase of COVID-19. COVID-19 vaccination may reduce the risk of long COVID. Rehabilitation can have a positive impact on recovery. This study aims to present the experiences of people with long COVID with COVID-19 vaccination and rehabilitation. Such research is important because perceptions of these measures can impact healthcare utilization and health status.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">48 adults with long COVID participated in this qualitative study, 25 of them in one-on-one interviews and 23 in focus groups. Participants were recruited via calls for participation on the websites and social media channels of two university hospitals and with the help of respondents' networks. The conversations were audio-recorded, transcribed, and analyzed using qualitative content analysis. Subsequently, the results were compared, interpreted, and discussed by scientific literature.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">35 study participants reported that they had received a COVID-19 vaccination and 16 of them stated that they had utilized a rehabilitation service. These participants had varying experiences with COVID-19 vaccination and rehabilitation. Nine of them stated that they developed long COVID despite vaccination before COVID-19. Ten participants reported vaccine reactions, and two participants reported severe side effects. Two participants reported persistent deterioration of their long COVID symptoms after vaccination. This led to uncertainty about the safety, benefits, and handling of COVID-19 vaccination. However, most participants perceived the vaccine as effective regarding milder COVID-19 sequelae. Four participants felt their rehabilitation was helpful and four participants felt it was unhelpful. Two persons found the combination of inpatient rehabilitation and rehabilitation sport helpful.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Several implications can be derived from this study: (1) researchers should explore the effects of COVID-19 vaccination on long COVID symptoms; (2) vaccination campaigns should be more responsive to the perspectives of people with long COVID on vaccination; (3) care planners should build rehabilitation facilities specialized in long COVID; (4) rehabilitation providers should train their professionals regarding long COVID and develop rehabilitation programs tailored to different clinical pictures.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">German register for clinical trials DRKS00026007, 09 September 2021.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmachtenberg</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, Humboldtallee 38, 37073, G&#xf6;ttingen, Germany. tim.schmachtenberg@med.uni-goettingen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. tim.schmachtenberg@med.uni-goettingen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;nigs</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, Humboldtallee 38, 37073, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roder</LastName><ForeName>Sascha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, Humboldtallee 38, 37073, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Work, University of Applied Sciences and Arts Bielefeld, Interaktion 1, 33619, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, Humboldtallee 38, 37073, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, College of Human Medicine, Michigan State University, 15 Michigan St NE, Grand Rapids, 49503, East Lansing, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;llenmeister</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, Humboldtallee 38, 37073, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schr&#xf6;der</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, Humboldtallee 38, 37073, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Sayed</LastName><ForeName>Iman</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of General Practice, University Medical Center G&#xf6;ttingen, Humboldtallee 38, 37073, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000068397">Clinical Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Population" UI="C000724523">German people</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">Germany</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Qualitative study</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>0</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38549052</ArticleId><ArticleId IdType="pmc">PMC10976759</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-18380-6</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-18380-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Center for Systems Science and Engineering at Johns Hopkins University. COVID-19 Dashboard. Date accessed March 10, 2023. Available from: https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Robert Koch Institut. COVID-19: Fallzahlen in Deutschland und weltweit. Coronavirus SARS-CoV-2. Date accessed March 10, 2023. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Fallzahlen.html/.</Citation></Reference><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hansen S, et al. Long COVID through Public Health Lens: Umbrella Rev Public Health Reviews. 2022;43. 10.3389/phrs.2022.1604501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert Koch Institut. Was ist Long COVID? Coronavirus SARS-CoV-2. Date accessed February 21. 2023. Available from: https://www.rki.de/SharedDocs/FAQ/NCOV2019/FAQ_Long-COVID_Definition.html.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network, and Royal College of General Practitioners. COVID-19 rapid guideline: managing the long-term effects of COVID-19. Date accessed February 21. 2023. Available from: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation></Reference><Reference><Citation>Herzog A. Das lange Leiden beim Long-COVID-Syndrom: Diagnostik, konventionelle und komplement&#xe4;re Therapie. Die Naturheilkunde. 2021;3. Date accessed February 21, 2023. Available from: https://www.fachklinikdrherzog.de/wp-content/uploads/2021/08/Naturheilkunde-Journal-Long-Covid-Herzog_11.06.2021.pdf.</Citation></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera S, McMullan C, Chandan JS, et al. &#x201e;Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;42. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after Hospital Discharge. JAMA Netw Open. 2021;4(1). 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha C, Baek G. &#x201e;Symptoms and management of long COVID: a scoping review. J Clin Nurs. 2021 doi: 10.1111/jocn.16150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16150</ArticleId><ArticleId IdType="pubmed">34913540</ArticleId></ArticleIdList></Reference><Reference><Citation>Degen CV, Mikuteit M, Niewolik J, Schr&#xf6;der D, Vahldiek K, M&#xfc;cke U, et al. &#x201e;Self-reported Tinnitus and Vertigo or Dizziness in a cohort of adult long COVID patients. Front Neurol. 2022;13:884002. doi: 10.3389/fneur.2022.884002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.884002</ArticleId><ArticleId IdType="pmc">PMC9082801</ArticleId><ArticleId IdType="pubmed">35547372</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Tejadaet CE, Herrera-Garc&#xed;a C, Godina-Gonz&#xe1;lez S, Villagrana-Ba&#xf1;uelos K, Amaro JD, Herrera-Garc&#xed;a K, et al. Persistence of COVID-19 symptoms after recovery in Mexican Population. Int J Environ Res Public Health. 2020;17(24). 10.3390/ijerph17249367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Homann S, Mikuteit M, Niewolik J, Behrens GMN, St&#xf6;lting A, M&#xfc;ller F, et al. Effects of Pre-existing Mental conditions on fatigue and psychological symptoms Post-COVID-19. Int J Environ Res Public Health. 2022;19(16). 10.3390/ijerph19169924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9408008</ArticleId><ArticleId IdType="pubmed">36011559</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. &#x201e;Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlis C, Barradell A, Gardiner NY, Chaplin E, Goddard A, Singh SJ, et al. &#x201e;The Recovery Journey and the Rehabilitation Boat: a qualitative study to explore experiences of COVID-19 rehabilitation. Chronic Resp Dis. 2022;19:1479973122111426. doi: 10.1177/14799731221114266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731221114266</ArticleId><ArticleId IdType="pmc">PMC9297070</ArticleId><ArticleId IdType="pubmed">35850558</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, Franco-L&#xf3;pez F, Buendia-Romero &#xc1;, Martinez-Cava A, S&#xe1;nchez-Agar JA, S&#xe1;nchez-Alcarez BJ, Martinez, et al. &#x201e;Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: a randomized controlled trial. Scand J Med Sci Sports. 2022;32(12):1791&#x2013;801. doi: 10.1111/sms.14240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sms.14240</ArticleId><ArticleId IdType="pmc">PMC9538729</ArticleId><ArticleId IdType="pubmed">36111386</ArticleId></ArticleIdList></Reference><Reference><Citation>RS, Hinman, Maher CG. Rehabilitation for post-covid-19 condition. BMJ. 2024;384. 10.1136/bmj.q20.</Citation><ArticleIdList><ArticleId IdType="pubmed">38325886</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Pozas O, Mel&#xe9;ndez-Oliva E, Rolando LM, Rico JAQ, Corbellini C. S&#xe1;nchez Romero. The pulmonary rehabilitation effect on long covid-19 syndrome: a systematic review and meta-analysis. Physiother Res Int. 2024;29(2). 10.1002/pri.2077.</Citation><ArticleIdList><ArticleId IdType="pubmed">38389299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Chen XK, Sit CHP, Liang X, Li MH, Ma ACH, et al. &#x201e;Effect of Physical Exercise-Based Rehabilitation on Long COVID: a systematic review and Meta-analysis. Med Sci Sports. 2024;56(1):143&#x2013;54. doi: 10.1249/MSS.0000000000003280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000003280</ArticleId><ArticleId IdType="pubmed">37586104</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutsch M, Sch&#xfc;ller PO, Buhr-Schinner H, Gross T, Deck R. &#x201e;Pneumologische Rehabilitation Im Antragsheilverfahren Bei Long COVID: Eine vergleichende explorative L&#xe4;ngsschnittstudie Mit Long-COVID- Und Asthma-/COPD-Rehabilitand*innen. Pneumologie. 2024;78(2):107&#x2013;19. doi: 10.1055/a-2215-3067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-2215-3067</ArticleId><ArticleId IdType="pubmed">38190991</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnier F, B&#xe9;rub&#xe9; B, Malo J, Gagnon C, Gr&#xe9;goire CA, Juneau M, et al. Cardiopulmonary Rehabilitation in Long-COVID-19 patients with persistent breathlessness and fatigue: the COVID-Rehab Study. Int J Environ Res Public Health. 2022;19(7). 10.3390/ijerph19074133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8998214</ArticleId><ArticleId IdType="pubmed">35409815</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarnakar R, Yadav S. &#x201e;Rehabilitation in long COVID-19: a mini-review. World J Methodol. 2022;12(4):235&#x2013;45. doi: 10.5662/wjm.v12.i4.235.</Citation><ArticleIdList><ArticleId IdType="doi">10.5662/wjm.v12.i4.235</ArticleId><ArticleId IdType="pmc">PMC9350732</ArticleId><ArticleId IdType="pubmed">36159093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesministerium f&#xfc;r Gesundheit, Institut RK. Paul-Ehrlich-Institut, and Bundeszentrale f&#xfc;r gesundheitliche Aufkl&#xe4;rung. Nationale Impfstrategie COVID-19: Strategie zur weiteren Durchf&#xfc;hrung und Evaluierung der Impfung gegen SARS-CoV-2 in Deutschland - aktualisiert. June 2021. Date accessed March 20, 2023. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/C/Coronavirus/Impfstoff/Nationale_Impfstrategie_Juni_2021.pdf</Citation></Reference><Reference><Citation>World Health Organization. Global Covid-19 Vaccination Strategy in a Changing World: July 2022 update. 2022. Date accessed March 20, 2023. Available from: https://www.who.int/publications/m/item/global-covid-19-vaccination-strategy-in-a-changing-world--july-2022-update</Citation></Reference><Reference><Citation>Bundesministerium f&#xfc;r Gesundheit and Robert Koch Institut. Wie ist der Fortschritt der COVID-19-Impfung? Aktueller Impfstatus. Date accessed March 10, 2023. Available from: https://impfdashboard.de/.</Citation></Reference><Reference><Citation>Venkatesan P. Do vaccines protect from long COVID? Lancet Respir Med. 2022;10(3). 10.1016/S2213-2600(22)00020-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776281</ArticleId><ArticleId IdType="pubmed">35065716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377. 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K. Glasziou. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1). 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul-Ehrlich-Institut. Safety Report. Langen, September 2022. Date accessed March 24, 2023. Available from: https://www.pei.de/SharedDocs/Downloads/EN/newsroom-en/dossiers/safety-reports/safety-report-27-december-2020-30-june-2022.pdf?__blob=publicationFile&amp;v=8.</Citation></Reference><Reference><Citation>Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Ling F, Olgin JE, et al. &#x201e;Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12):e2140364&#x2013;2140364. doi: 10.1001/jamanetworkopen.2021.40364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.40364</ArticleId><ArticleId IdType="pmc">PMC8696570</ArticleId><ArticleId IdType="pubmed">34935921</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmachtenberg T, M&#xfc;ller F, Kranz J, Dragaqina A, Wegener G, K&#xf6;nigs G. &#x201e;How do long COVID patients perceive their current life situation and occupational perspective? Results of a qualitative interview study in Germany. Front. Public Health. 2023;11:1155193. doi: 10.3389/fpubh.2023.1155193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1155193</ArticleId><ArticleId IdType="pmc">PMC10034079</ArticleId><ArticleId IdType="pubmed">36969629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikuteit M, Heinemann S, Roder S, Niewolik J, Schr&#xf6;der D, Vahldiek K, et al. &#x201e;Long term consequences of COVID-19 and the pandemic (the DEFEnse Against COVID-19 (DEFEAT CORONA) study protocol): an online-based longitudinal observational study. JMIR Res Protoc. 2022 doi: 10.2196/38718.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/38718</ArticleId><ArticleId IdType="pmc">PMC9611102</ArticleId><ArticleId IdType="pubmed">36108134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J. &#x201e;Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349&#x2013;57. doi: 10.1093/intqhc/mzm042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzm042</ArticleId><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Degen CV, Mikuteit M, Niewolik J, Joosten T, Schr&#xf6;der D, Vahldiek K, et al. &#x201e;Audiological profile of adult long COVID patients. Am J Otolaryngol. 2022;43(5):103579. doi: 10.1016/j.amjoto.2022.103579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2022.103579</ArticleId><ArticleId IdType="pmc">PMC9354445</ArticleId><ArticleId IdType="pubmed">35988361</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Successful qualitative research: a practical guide for beginners. Thousand Oaks, CA, USA: SAGE; 2013.</Citation></Reference><Reference><Citation>Fugard AJB, Potts HWW. &#x201e;Supporting thinking on sample sizes for thematic analyses: a quantitative tool. Int J Soc Res Methodol. 2015;18(6):669&#x2013;84. doi: 10.1080/13645579.2015.1005453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13645579.2015.1005453</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest G, Bunce A, Johnson L. Field Methods. 2006;18(1):59&#x2013;82. 10.1177/1525822X05279903. How Many Interviews Are Enough? An Experiment with Data Saturation and Variability.</Citation></Reference><Reference><Citation>Schulz M, Mack B, Renn O. Fokusgruppen in Der Empirischen Sozialwissenschaft: Von Der Konzeption Bis Zur Auswertung. Wiesbaden: Springer VS; 2012.</Citation></Reference><Reference><Citation>W. Mayerhofer. Das Fokusgruppeninterview. Qualitative Marktforschung: Konzepte - Methoden - Analysen. 2. Wiesbaden: Gabler, 2009.</Citation></Reference><Reference><Citation>Flick U. Qualitative Sozialforschung: Eine Einf&#xfc;hrung. 7. Reinbek near Hamburg: Rowohlt; 2016.</Citation></Reference><Reference><Citation>Fachhochschule, S&#xfc;dwestfalen. University of Applied Sciences, and City Lab S&#xfc;dwestfalen. Leitfaden Durchf&#xfc;hrung Fokusgruppen. Date accessed June 8, 2022. Available from: https://www.citylab-swf.de/wp-content/uploads/Leitfaden-Durchf%C3%BChrung-Fokusgruppen.pdf</Citation></Reference><Reference><Citation>Kolakowski P. Post Covid im Job: &#x201a;Ich bin nicht so wie vorher&#x2018;. SWR2. March 2, 2022. Date accessed June 5, 2022. Available from: https://www.swr.de/swr2/wissen/post-covid-im-job-ich-bin-nicht-so-wie-vorher-100.html.</Citation></Reference><Reference><Citation>Reichertz J. &#x201e;Die coronabedingte Krise Der Qualitativen Sozialforschung. Soziologie. Frankfurt am Main: Campus; 2021. pp. 313&#x2013;35.</Citation></Reference><Reference><Citation>Demmer I, El-Sayed I, Heinemann S, K&#xf6;nigs G, M&#xfc;ller F, M&#xfc;llenmeister C et al. (Er-)Leben mit Long COVID: Projektergebnisse einer qualitativen Studie bildhaft interpretiert. G&#xf6;ttingen: Sascha Roder. 2022. Date accessed November 30, 2022. Available from: https://generalpractice.umg.eu/fileadmin/Redaktion/Allgemeinmedizin/Dokumente/DEFEAT_Corona_Bildband.pdf.</Citation></Reference><Reference><Citation>Dresing T, Pehl T. Praxisbuch Interview: Transkription &amp; Analyse. Anleitungen und Regelsysteme f&#xfc;r qualitativ Forschende. 8. Marburg, 2018.</Citation></Reference><Reference><Citation>Kuckartz U, Dresing T, R&#xe4;diker S. Claus. Qualitative evaluation: Der Einstieg in die praxis. Wiesbaden: VS Verlag f&#xfc;r Sozialwissenschaften; 2008.</Citation></Reference><Reference><Citation>Kuckartz U, R&#xe4;diker S. Qualitative inhaltsanalyse: Methoden, Praxis, Computerst&#xfc;tzung. Grundlagentexte Methoden. 5 ed. Beltz; 2022.</Citation></Reference><Reference><Citation>Mayring P. Qualitative inhaltsanalyse: Grundlagen Und Techniken. 13. Beltz; 2022.</Citation></Reference><Reference><Citation>Bundesministerium f&#xfc;r Gesundheit. Das deutsche Gesundheitssystem: Leistungsstark. Sicher. Bew&#xe4;hrt. Berlin. 2020. Date accessed April 12, 2023. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Gesundheit/Broschueren/200629_BMG_Das_deutsche_Gesundheitssystem_DE.pdf.</Citation></Reference><Reference><Citation>Bundeszentrale f&#xfc;r gesundheitliche Aufkl&#xe4;rung. Sie haben eine Frage zum Infektionsschutz? Finden Sie Antworten hier! infektionsschutz.de. October 10. 2022. Date accessed April 12, 2023. Available from: https://www.infektionsschutz.de/mediathek/fragen-antworten/?tx_sschfaqtool_pi1%5Baction%5D=list&amp;tx_sschfaqtool_pi1%5Bcontroller%5D=FAQ&amp;tx_sschfaqtool_pi1%5Bfaq%5D=4503&amp;cHash=c30d38349c370e7c96ec8cf6fd8a6625.</Citation></Reference><Reference><Citation>Deutsche Rentenversicherung. Warum Reha? Rehabilitation. Date accessed April 12. 2023. Available from: https://www.deutsche-rentenversicherung.de/DRV/DE/Reha/Warum-Reha/warum-reha.html.</Citation></Reference><Reference><Citation>Bundesministerium f&#xfc;r Gesundheit. Impfpriorisierung. Zusammen gegen Corona. February 10, 2023. Date accessed March 24, 2023. Available from: https://www.zusammengegencorona.de/faqs/impfen/aufhebung-der-impfpriorisierung/.</Citation></Reference><Reference><Citation>Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Bruns F, et al. &#x201e;Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med. 2021;385(13):1172&#x2013;83. doi: 10.1056/NEJMoa2107659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107659</ArticleId><ArticleId IdType="pmc">PMC8262625</ArticleId><ArticleId IdType="pubmed">34192426</ArticleId></ArticleIdList></Reference><Reference><Citation>Uttarilli A, Amalakanti S, Kommoju P, Sharma S, Goyal P, Manjunath G, et al. &#x201e;Super-rapid race for saving lives by developing COVID-19 vaccines. J Integr Bioinform. 2021;18(1):27&#x2013;43. doi: 10.1515/jib-2021-0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jib-2021-0002</ArticleId><ArticleId IdType="pmc">PMC8035961</ArticleId><ArticleId IdType="pubmed">33761582</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert Koch Institut. Sicherheit von Impfungen. Impfen. February 26. 2021. Date accessed March 16, 2023. Available from: https://www.rki.de/DE/Content/Infekt/Impfen/Nebenwirkungen/nebenwirkungen_node.html.</Citation></Reference><Reference><Citation>&#xd6;z&#xfc;temiz C, Krystoseket LA, Church AL, Chauhan A, Ellermann JM, Domingo-Musibay E, et al. &#x201e;Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients. Radiology. 2021;300(1):E296&#x2013;300. doi: 10.1148/radiol.2021210275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210275</ArticleId><ArticleId IdType="pmc">PMC7909072</ArticleId><ArticleId IdType="pubmed">33625300</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller T. &#x201e;Metastase? Nein, eine COVID-19-Impfreaktion! hautnah dermatologie. 2021;37(3):10&#x2013;10. doi: 10.1007/s15012-021-6678-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15012-021-6678-9</ArticleId></ArticleIdList></Reference><Reference><Citation>57. Paul-Ehrlich-Institut. Verdachtsf&#xe4;lle von Nebenwirkungen und Impfkomplikationen nach Impfung zum Schutz vor COVID-19 seit Beginn der Impfkampagne am 27.12.2020 bis zum 30.06.2021&#x201c;. Langen. Sicherheitsbericht. July 2021. Date accessed March 16, 2023. Available from: file:///C:/Users/schmachtenbe/Downloads/2021_Paul-Ehrlich-Institut_Verdachtsf%C3%A4lle%20von%20Nebenwirkungen%20und%20Impfkom....pdf.</Citation></Reference><Reference><Citation>Mentzer D, Keller-Stanislawski B. Verdachtsf&#xe4;lle von Nebenwirkungen oder Impfkomplikati- onen nach Impfung mit den Omikron-adaptierten bivalenten COVID-19-Impfstoffen Comirnaty Original/Omicron BA.1, Comirnaty Original/Omicron BA.4&#x2013;5, Spikevax bivalent/ Omicron BA.1 (bis 31.10.2022 in Deutschland gemeldet). Paul-Ehrlich-Institut. December 4, 2022. Date accessed March 16, 2023. Available from: https://www.pei.de/SharedDocs/Downloads/DE/newsroom/dossiers/sicherheitsberichte/sicherheitsbericht-27-12-20-bis-31-10-22-aus-bulletin-zur-arzneimittelsicherheit-4-2022-s-29-34.pdf?__blob=publicationFile&amp;v=4.</Citation></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L. Rossman. The impact of COVID vaccination on symptoms of long COVID: an International Survey of people with lived experience of long COVID. Vaccines. 2022;10(5). 10.3390/vaccines10050652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A, Sheikh AA, Khan AM, Khalid S, Khan J, Nasrullah A, et al. COVID-19 vaccine and Long COVID: a scoping review. Life. 2022;12(7). 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Perrodeau E, Saldanha J, Pane I, Ravaud P. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2(1). 10.1136/bmjmed-2022-000229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco J, Pastrana A, Ver AT, Pangilinan F, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. 2022;53. 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. &#x201e;Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. 2023;41(11):1783&#x2013;90. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky JP, Govindarajulu U, Bagiella E, Goswami R, Kale M, Campbell KN, et al. &#x201e;Association of Vaccination with the persistence of Post-COVID symptoms. J Gen Intern Med. 2022;37(7):748&#x2013;1753. doi: 10.1007/s11606-022-07465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauernfeind S, Schmidt B. &#x201e;Stellenwert Der COVID-19-Impfung im Kontext Von Long-COVID. Die Innere Medizin. 2022;63(8):840&#x2013;50. doi: 10.1007/s00108-022-01368-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00108-022-01368-y</ArticleId><ArticleId IdType="pmc">PMC9261894</ArticleId><ArticleId IdType="pubmed">35925072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegwarth O, Kendel F, Tomsic I, von Lengerke T. H&#xe4;rter. &#x201e;Die COVID-19-Pandemie: Wie Gelingt Eine Transparente Kommunikation Von Risiken? Public Health Forum. 2021;29(1):27&#x2013;31. doi: 10.1515/pubhef-2020-0113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/pubhef-2020-0113</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergner S, Gr&#xfc;ger T, Huber M, L&#xfc;tkeherm&#xf6;lle W, Paeschke N, Palissa H, et al. &#x201e;Instrumente beh&#xf6;rdlicher Kommunikation zu Anwendungsrisiken Von Arzneimitteln. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2022;65(5):567&#x2013;76. doi: 10.1007/s00103-022-03527-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-022-03527-w</ArticleId><ArticleId IdType="pmc">PMC9039600</ArticleId><ArticleId IdType="pubmed">35471605</ArticleId></ArticleIdList></Reference><Reference><Citation>Loss J, Boklage E, Jordan S, Jenny MA, Weishaar H. El Bcheraoui. &#x201e;[Risk communication in the containment of the COVID-19 pandemic: challenges and promising approaches] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;64(3):294&#x2013;303. doi: 10.1007/s00103-021-03283-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-021-03283-3</ArticleId><ArticleId IdType="pmc">PMC7872109</ArticleId><ArticleId IdType="pubmed">33564896</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller F, Heinemann S, Hummers E, Noack EM, Heesen G, Dopfer-Jablonka A, et al. &#x201e;Impfeinstellung, Erwartungen Und Impferfahrung Von Immunsupprimierten Bei COVID-19-Impfungen. Z f&#xfc;r Rheumatologie. 2022 doi: 10.1007/s00393-022-01213-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00393-022-01213-5</ArticleId><ArticleId IdType="pmc">PMC9075708</ArticleId><ArticleId IdType="pubmed">35523964</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagger MS, Smith SR, Keech JJ, Moyers SA. Hamilton. &#x201e;Predicting physical distancing over time during COVID-19: testing an integrated model. Psychol Health. 2022;37(12):1436&#x2013;56. doi: 10.1080/08870446.2021.1968397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08870446.2021.1968397</ArticleId><ArticleId IdType="pubmed">34435916</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark C, Davila A, Regis M, Kraus S. Predictors of COVID-19 voluntary compliance behaviors: an international investigation. Glob Transit. 2020;2:76&#x2013;82. doi: 10.1016/j.glt.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.glt.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7318969</ArticleId><ArticleId IdType="pubmed">32835202</ArticleId></ArticleIdList></Reference><Reference><Citation>Dror AA, Eisenbach N, Taiber S, Mozorov N, Mizrachi M, Zigron A, et al. &#x201e;Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775&#x2013;9. doi: 10.1007/s10654-020-00671-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00671-y</ArticleId><ArticleId IdType="pmc">PMC8851308</ArticleId><ArticleId IdType="pubmed">32785815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashte S, Gulbake A, El-Amin SF, Iii, Gupta A. &#x201e;COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021;34(3):711&#x2013;33. doi: 10.1007/s13577-021-00512-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-021-00512-4</ArticleId><ArticleId IdType="pmc">PMC7937046</ArticleId><ArticleId IdType="pubmed">33677814</ArticleId></ArticleIdList></Reference><Reference><Citation>van Mulukom V, Pummerer LJ, Alper S, Bai H, &#x10c;avojov&#xe1; V, Farias J et al. Antecedents and consequences of COVID-19 conspiracy beliefs: a systematic review. Soc Sci Med 301: 114912. 10.1016/j.socscimed.2022.114912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920084</ArticleId><ArticleId IdType="pubmed">35354105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton K, Hagger MS. The vaccination concerns in COVID-19 scale (VaCCS): development and validation. PLoS ONE 17(3): 1&#x2013;33. 10.1371/journal.pone.0264784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920277</ArticleId><ArticleId IdType="pubmed">35286331</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A. Reha nach Corona: So hilft sie Akut- und Long Covid-Patienten. April 26, 2021. Date accessed March 14, 2023. Available from: https://www.ihre-vorsorge.de/magazin/lesen/reha-nach-corona-so-hilft-sie-akut-und-long-covid-patienten.html.</Citation></Reference><Reference><Citation>Fugazzaro S, Contri A, Esseroukh O, Kaleci S, Croci S, Massari M, et al. Rehabilitation interventions for Post-acute COVID-19 syndrome: a systematic review. Int J Environ Res Public Health. 2022;19(9). 10.3390/ijerph19095185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9104923</ArticleId><ArticleId IdType="pubmed">35564579</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, Gattinger D, Petrovic M, Vonbank K, et al. &#x201e;Outpatient Pulmonary Rehabilitation in patients with long COVID improves Exercise Capacity, Functional Status, Dyspnea, fatigue, and Quality of Life. Respiration. 2022;101(6):593&#x2013;601. doi: 10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P. &#x201e;Schlafst&#xf6;rungen Und Ersch&#xf6;pfungssyndrom Bei Long-COVID-Syndrom: Fallbasierte Erfahrungen Aus Der neurologischen/schlafmedizinischen Rehabilitation. Somnologie. 2022;26(2):73&#x2013;9. doi: 10.1007/s11818-022-00353-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11818-022-00353-9</ArticleId><ArticleId IdType="pmc">PMC9149331</ArticleId><ArticleId IdType="pubmed">35669940</ArticleId></ArticleIdList></Reference><Reference><Citation>Compagno S, Palermi S, Pescatori V, Brugin E, Sarto M, Marin R, et al. &#x201e;Physical and psychological reconditioning in long COVID syndrome: results of an out-of-hospital exercise and psychological - based rehabilitation program. IJC Heart Vasculature. 2022;41:101080. doi: 10.1016/j.ijcha.2022.101080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101080</ArticleId><ArticleId IdType="pmc">PMC9286763</ArticleId><ArticleId IdType="pubmed">35854691</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowska M, Rzepka-Cholasi&#x144;ska A, Pietrzykowski &#x141;, Michalski P, Kosobucka-Ozdoba A, Jasiewicz M, et al. Effects of Multidisciplinary Rehabilitation Program in patients with long COVID-19: Post-COVID-19 Rehabilitation (PCR SIRIO 8) study. J Clin Med. 2023;12(2). 10.3390/jcm12020420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9864838</ArticleId><ArticleId IdType="pubmed">36675349</ArticleId></ArticleIdList></Reference><Reference><Citation>Harenwall S, Heywood-Everett S, Henderson R, Godsell S, Jordan S, Moore A, et al. &#x201e;Post-Covid-19 syndrome: improvements. Virtual Rehabilitation J Prim Care Community Health. 2021;12:21501319211067670. doi: 10.1177/21501319211067674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319211067674</ArticleId><ArticleId IdType="pmc">PMC8721676</ArticleId><ArticleId IdType="pubmed">34939506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stevens JS, et al. &#x201e;Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P. Diaz. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4). 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>